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Affinity purified antibodies to human sex hormone binding globulin (SHBG) were used in screening a hu- 
man liver cDNA library, constructed in the expression vector lgtl 1. One clone, identified as producing re- 
combinant SHBG, carried a cDNA insert of 1.1 kb. The nucleotide sequence of the insert had an open read- 
ing frame coding for 356 amino acid residues. The coding sequence was followed by a short 3’-region of 
19 non-translated nucleotides and a poly(A) tail. Confirmation that the cDNA clone represented human 
SHBG was obtained by the finding of a complete agreement in amino acid sequence with several peptide 
fragments generated from purified SHBG by proteolytic cleavage. The primary structure of SHBG shows 
a considerable homology to that of protein S, a vitamin K-dependent protein with functions in the coagu- 
lation system. 
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1. INTRODUCTION 
Sex hormone binding globulin (SHBG) is an im- 
portant carrier of sex steroids in plasma [I]. It is 
thought to be synthesized in the liver [2] and the 
concentration of SHBG in plasma is dependent on 
several hormones, being increased by estrogens 
and thyroid hormones and decreased by an- 
drogens. Human SHBG is a dimeric protein with 
a molecular mass of approx. 100 kDa. It is com- 
posed of two identical or very similar, non- 
covalently associated protomers. Only one steroid 
molecule is bound per dimeric protein, but little 
else is known about the mechanisms for the steroid 
binding [3-51. 
The protomers of SHBG vary in size, two main 
size classes having usually been observed, one 
heavier and one lighter occurring at an approx- 
imate ratio of 10: 1 [6,7]. However, it has recently 
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been demonstrated that this only represents the 
prevailing pattern, occurring in 80% of the 
population. In the remaining 20% there are three 
different sizes of the SHBG protomer [8]. 
Previous reports on the carbohydrate structure 
[4,9,10] and partial amino acid sequences of 
human SHBG [3,7] have recently been com- 
plemented with the complete amino acid sequence 
of the human SHBG protomer [4]. None of these 
reports, however, explains the observed variation 
in size of the SHBG protomer. 
To gain further knowledge of the structure of 
SHBG and its possible variation, and to permit 
studies of its gene structure and of its biosynthesis 
in various organs, we have isolated a cDNA clone 
coding for SHBG from a human liver cDNA 
library. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Chemicals used for amino acid analysis were ob- 
tained from Beckman Instruments, and for protein 
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sequence determination from Applied Biosystems. 
Solvents for HPLC were from Rathburn. TPCK- 
trypsin was obtained from Sigma and Staphylo- 
coccus aureus protease V8 from Miles. A hgt 11 
screening kit was purchased from Promega Bio- 
techniques. The Klenow fragment of DNA poly- 
merase 1 was obtained from Boehringer Mann- 
heim. The restriction enzymes EcoRI and StuI 
were from Amersham, who also supplied cy- 
[35S]thio-dATP (22 TBq/mmol). Deoxynucleo- 
tides, dideoxynucleotides, Tq DNA polymerase 
and the replicative form of the phage Ml3 mp18 
were purchased from Pharmacia. An antiserum to 
human SHBG has been described [l 11. It was af- 
finity purified on a column of agarose coupled 
with SHBG, purified as described [ 121. 
2.2. Isolation of cDNA clones and DNA 
sequencing 
A Xgtl 1 cDNA library prepared from human 
liver poly(A)+ RNA was kindly provided by Dr 
Savio L. Woo. The library was screened according 
to the procedures described by Young and Davis 
[ 13,141, using affinity purified rabbit anti-human 
SHBG as first antibody and an alkaline 
phosphatase labelled goat anti-rabbit im- 
munoglobulin for detection. Recombinant phages 
were purified from plate lysates by centrifugation 
in a CsCl gradient, and the DNA was extracted by 
standard procedures [ 151. Sequencing of DNA was 
carried out on material subcloned in M 13 mp 18 ac- 
cording to Sanger et al. [16] as modified by Biggin 
et al. [17]. Nucleotide sequences were aligned and 
analyzed with computer programs kindly provided 
by R. Staden, Medical Research Council Unit, 
Cambridge [ 18,191 and the Protein Identification 
Resource [20]. 
2.3. Isolation and sequencing of peptide 
fragments 
Human SHBG (1.4 mg), purified as described 
[ 121, was dialyzed at 4°C against 6 M guanidine 
HCl and 5 mM EDTA in 0.5 M Tris-HCl buffer, 
pH 8.0. The dialyzed sample was flushed with Nz 
and reduced by adding 3.1 ,umol of dithiothreitol 
followed by incubation at 37°C for 4 h. Alkylation 
was done with 7.8 pmol of solid, recrystallized, 
iodoacetic acid and the mixture was left for 2 h in 
the dark at room temperature with gentle agita- 
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tion. The sample was dialyzed against 0.1 M am- 
monium bicarbonate buffer, pH 7.5, followed by 
evaporation. The residue was dissolved in 200 ~1 of 
the ammonium bicarbonate buffer and treated 
with 28 pg of trypsin or S. aureus protease V8 for 
2 h at 37°C. The sample was evaporated to 
dryness, which was repeated twice after the addi- 
tion of redistilled water to remove salt thoroughly. 
High-performance liquid chromatography 
(HPLC) was performed at room temperature on a 
PBondapak column (0.39 x 30 cm) eluted at a flow 
rate of 0.8 ml/min with a linear gradient from sol- 
vent A: solvent B (95 : 5, v/v) to solvent A: solvent 
B (30 : 70, v/v) developed over 1 h. Solvent A was 
0.08% trifluoroacetic acid in water and solvent B 
acetonitrile. Fractions corresponding to peptide 
peaks were pooled and lyophilized. One half of the 
material from each isolated peptide was subjected 
to amino acid analysis and the other to sequence 
determination. Amino acid sequence and composi- 
tion of .peptides were determined on an Applied 
Biosystems gas-phase sequencer and a Beckman 
6300 amino acid analyzer, respectively, as describ- 
ed [21]. 
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Fig. 1. Restriction map and sequencing strategy (a) and 
nucleotide sequence with predicted amino acid sequence 
(b) of human SHBG cDNA. (a) Restriction 
endonuclease cleavage sites are shown above the linear 
map; arrows, DNA fragments sequenced. (b) Nucleotide 
sequence of the cDNA presented in the 5’ to 3 ’ 
orientation. The longest translational open reading 
frame is shown above the nucleotide sequence. Numbers 
to the right of the sequences indicate amino acid residue 
(upper) and nucleotide (lower). Number 18 is assigned to 
the first amino acid residue for reasons given in the text. 
Amino acid sequences also determined in peptides 
(generated from purified SHBG by proteolytic cleavage) 
are underlined. 
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Val His Ser Ala Ala Gln Thr Thr 
CT GTC CAC TCG GCG GCT CAG ACA ACT 
Leu Ile Ala Val Met Thr Phe Asp J,eu Thr JWS 36 
CTT ATC GCT GTC ATG ACC TTT GAC CTC ACC AAG 59 
Ile Thr JNS Thr Set Ser Ser Phe Glu Val Arg Thr Trw Asp Pro Glu Glv Val Ile P& 56 
ATC ACA AAA ACC TCC TCC TCC TTT GAG GTT CGA ACC TGG GAC CCA GAG GGA GTG ATT TTT 119 
e-3 Lys As&_&p Trp Phe Met Leu Gly Leu Arg wu PrQ 76 
TAT GGG GAT ACC AAC CCT AAG GAT GAC TGG TTT ATG CTG GGA CTT CGA GAC GGC AGG CCT 179 
Glu His Trp Ala Gln Leu Thr Val Gly Ala Gly Pro Arg Ileum 96 
GAG ATC CAA CTG CAC AAT CAC TGG GCC CAG CTT ACG GTG GGT GCT GGA CCA CGG CTG GAT 239 
Asw Glv Arg Trw His Gln Val Glu Val Lys r L V 116 
GAT GGG AGA TGG CAC CAG GTG GAA GTC AAG ATG GAG GGG GAC TCT GTG CTG CTG GAG GTG 299 
Asw Glv Mu Glu Val, Leu Arg Leu Arg Gln Val Ser Gly Pro Leu Thr Ser Lys Arg His 136 
GAT GGG GAG GAG GTG CTG CGC CTti AGA CAG GTC TCT GGG CCC CTG ACC AGC AAA CGC CAT 359 
Pro Ile Met Arg U..e Ala JRU Gly Gly Jeu JRU Phe Pro Ala Ser Asn Leu Arg ku PrQ 156 
CCC ATC ATG AGG ATT GCG CTT GGG GGG CTG CTC TTC CCC GCT TCC AAC CTT CGG TTG CCG 419 
Leu Val Pro Al_a J,eu Asp Glv Cys Jeeu A.rg Arg Asp Ser Trp Leu Asp Lys Gln Ala Glu 176 
CTG GTT CCT GCC CTG GAT GGC TGC CTG CGC CGG GAT TCC TGG CTG GAC AAA CAG GCC GAG 479 
Ile Ser Ala Ser Ala Pro Thr Ser Leu Arg Ser 196 
ATC TCA GCA TCT GCC CCC ACT AGC CTC AGA AGC TGT GAT GTA GAA TCA AAT CCC GGG ATA 539 
Phe J,eu Pro Pro Glv Thr Gln Ala Glu Phe Asn Jeu Ara ASD Ile Pro Gln Pro His Ala 216 
TTT CTC CCT CCA GGG ACT CAG GCA GAA TTC AAT CTC CGA GAC ATT CCC CAG CCT CAT GCA 599 
au Pro Trp ALa Phe Ser Leu Asp Leu Gly Leu Lys Gln Ala Ala Gly Ser Gly His Leu 236 
GAG CCC TGG GCC TTC TCT TTG GAC CTG GGA CTC AAG CAG GCA GCA GGC TCA GGC CAC CTC 659 
Leu Ala Leu Gly Thr Pro Glu Asn Pro Ser Trp Leu Ser Leu His Leu Gln Asp Gln Lys 256 
CTT GCT CTT GGG ACA CCA GAG AAC CCA TCT TGG CTC AGT CTC CAC CTC CAA GAT CAA AAG 719 
Val Val Leu Ser Ser Gly Ser Gly Pro Gly Leu Asp Leu Pro Leu Val Leu Gly Leu Pro 276 
GTG GTG TTG TCT TCT GGG TCG GGG CCA GGG CTG GAT CTG CCC CTG GTC TTG GGA CTC CCT 779 
Leu Gln Leu Lys Leu Ser Met Ser Arg Val Val Leu Ser Gln Gly Ser Lys Met Lys 2Ua 296 
CTT CAG CTG AAG CTG AGT ATG TCC AGG GTG GTC TTG AGC CAA GGG TCG AAG ATG AAG GCC 839 
v Leu Ala Pro T.eu JRU Am Leu Trp._Ala Lys Pro Gin 
CTT GCC CTG CCT CCC TTA GGC CTG GCT CCC CTC CTT AAC CTC TGG GCC AAG CCT CAA GGG 
Arg Leu Phe Leu Gly Ala Leu Pro Gly Glu Asp Ser Ser Thr Ser Phe Cys Leu Asn Gly 
CGT CTC TTC CTG GGG GCT TTA CCA GGA GAA GAC TCT TCC ACC TCT TTT TGC CTG AAT GGC 
Leu Trp Ala Gln Gly Gln Arg Leu Asp Val Asp Gln Ala Leu Asn Arg $er His Glu Ile 
CTT TGG GCA CAA GGT CAG AGG CTG GAT GTG GAC CAG GCC CTG AAC AGA AGC CAT GAG ATC 
Trp Thr His Ser Cvs Pro Gin Ser Pro Glv Asn Glv Thr Asw Ab Ser His 
TGG ACT CAC AGC TGC CCC CAG AGC CCA GGC AAT GGC ACT GAC GCT TCC CAT TAA AGCTCCA 
316 
899 
336 
959 
356 
1019 
1080 
CCTAAGAACCCCA 
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3. RESULTS 
3.1. Isolation and sequencing of a human SHBG 
cDNA clone 
Approximately 1.2 x lo6 recombinants, in a 
hgt 11 human liver cDNA library were screened. 
One clone, designated ASHBG-1, was isolated, the 
DNA of which was digested with EcoRI and then 
analyzed by agarose gel electrophoresis. In addi- 
tion to the vector bands, two bands were seen, one 
representing a fragment of approximately 560 
nucleotides, the other of 450. The EcoRI 
fragments were isolated and subcloned in 
bacteriophage Ml3 mp18. The ends of the 
subcloned DNA were sequenced, yielding approx- 
imately 90% of the sequence of the whole cDNA 
insert. From analysis of the partial sequence, two 
suitably located StuI cleavage sites were found. By 
combined EcoRI and StuI digestion, fragments 
were generated that yielded enough data to com- 
plete the sequence of the XSHBG-1 cDNA insert. 
Fig. la gives an outline of the sequencing strategy. 
The nucleotide and derived amino acid sequences 
for the cloned SHBG cDNA are given in fig.lb. 
The length is 1110 base pairs, including a short 
poly(A) tail of 18 nucleotides. The coding region, 
encoding 356 amino acids, extends from the begin- 
ning of the insert to a stop codon, TAA, at posi- 
tion 1071-1073. The stop codon is also part of the 
polyadenylation signal, ATTAAA. A stretch of 19 
non-translated nucleotides separates the coding 
region from the poly(A) tail. 
3.2. Comparison of the deduced amino acid 
sequence with peptide fragments of SHBG 
A trypsin digest of reduced and alkylated human 
SHBG was separated by HPLC. Nine pure pep- 
tides and two fractions, each a mixture of two pep- 
tides, were obtained. Similarly, six pure peptides 
were isolated from a digest of reduced and 
alkylated SHBG obtained with the S. aureus pro- 
tease V8. For both digests, the yield of each pep- 
tide was about 10%) which probably should not be 
regarded as low when considering the small scale 
on which the isolations had to be carried out. 
The isolated peptides were sequenced and all of 
them could be identified as parts of the amino acid 
sequence deduced from the nucleotide sequence of 
the cDNA. The parts of the deduced sequence cor- 
responding to the peptides are underlined in fig. lb. 
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The peptide sequence data accounted for 
altogether 49% of the entire deduced amino acid 
sequence (fig.lb) and there were no peptide se- 
quences that could not be found in the deduced se- 
quence. 
The SHBG cDNA contains one internal EcoRI 
restriction site (fig.lb), and this site is not over- 
lapped by any of the DNA sequences (fig. la). It is, 
however, overlapped by one long tryptic peptide 
(fig.lb) thus excluding the presence of more than 
one EcoRI cleavage site. 
Comparison of the deduced amino acid se- 
quence with the recently published protein se- 
quence of the SHBG protomer [4] shows a 
complete agreement from residue 27 in the pub- 
lished sequence to its end. The amino acid residues 
in fig. 1 b have therefore been numbered to coincide 
with the published sequence, the only discrepancy 
being in the amino-terminal part; the first nine 
amino acids, which should correspond to amino 
acid residues 18-26 in the published sequence, are 
completely different. 
3.3. Homology to vitamin K-dependent protein S 
An alignment of human SHBG with bovine and 
human protein S [22,23] is shown in fig.2. The 
alignment shown was obtained by first aligning 
human SHBG separately with human and bovine 
protein S by means of a computer program [20]. 
All three sequences were then aligned with each 
other by making a few arbitrary adjustments which 
increased residue correspondence. The computer 
alignments with human and bovine protein S gave 
the maximal scores 252 and 264, respectively, when 
40 was used as a penalty for a break. The mean 
scores obtained with 100 random sequences, 
generated from an amino acid composition iden- 
tical to that of human SHBG, were 11.4 and 11.7 
for alignments with human and bovine protein S, 
respectively, with standard deviations 6.2 and 4.7. 
4. DISCUSSION 
Except for the nine amino acid residues coded 
for by the 5 ‘-end, the amino acid sequence de- 
duced from the cloned cDNA is in complete agree- 
ment with the recently published sequence of 
human SHBG determined by protein chemical 
methods [4]. Although the first 29 nucleotides of 
the cDNA (coding for nine amino acids) might 
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FLETKVYFAGVPRKMENALIRPINPR 
LLETKVYFAGFPRKVESELIKPINPR 
IMRIALGGLLaA uNl:LiLVuA 
240 
DNTVPFA 
260 280 
LSLVDSATEKLQDILVSVESMVIGRIEAISLCSDQQTFLE 
VSLVDSTSEKSQDILLSVENTVIYRIQALSLCSDQQSHLE 
PENPSWflHLQDiKVVL 
Fig.2. Amino acid sequence comparison between human SHBG (1ower)and the carboxy-terminal portions of human 
(middle)and bovine(upper)protein S. Aminoacid residuesmatchedin SHBGandin atleastoneoftheprotein Sspecies 
are boxed. Spaces represent gaps inserted to maximize the number of matches in the comparison. 
represent a cloning artefact, another explanation 
that cannot be ruled out is that the variant se- 
quence represents an SHBG subunit partly dif- 
ferent from that sequenced by Walsh et al. [4]. 
It is a well established fact that SHBG, which is 
a dimeric protein, contains subunits differing 
slightly in structure [3,6,7] and it has recently been 
shown that the SHBG subunits are not uniform in 
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all humans, 20% of the population having an extra 
SHBG subunit which is heavier than the usual two 
subunits [S]. The structure differences between the 
SHBG subunits may be due to different degrees of 
glycosylations or other posttranslational modifica- 
tions, but a difference in amino acid sequence is 
also a possibility. Such a variation in primary 
structure might result from an alternative splicing, 
for instance. 
If SHBG were purified from pooled plasma con- 
taining a minor amount of a subunit with a se- 
quence slightly different from that of the 
predominant form of the protein, sequence 
analysis would probably not detect the variant se- 
quence. In contrast, cloning of a cDNA would give 
one unique species, one that could represent a 
variant polypeptide. The resolution of the question 
of whether variation in the primary structure of the 
SHBG subunit exists must await the isolation of 
additional SHBG cDNA clones, studies of the 
SHBG gene and/or the sequencing of individual 
subunits of SHBG. 
When the amino acid sequence of human SHBG 
was reported SHBG was found not to be 
homologous to any other protein, thus implying it 
to be the single member of a new protein family 
[4]. Shortly afterwards, however, androgen 
binding protein (ABP) from rat testis was shown to 
have a high degree of homology to human SHBG 
[24]. Our comparison of the sequence of human 
SHBG with the sequences of bovine and human 
protein S, two proteins recently cloned and se- 
quenced [22,23,25], reveals a homology of human 
SHBG to protein S, not unexpected in the light of 
the observation [24] that rat ABP seems to be 
related to the carboxy-terminal region of protein S. 
Protein S is an important cofactor in the an- 
ticoagulation system [26] and has connections with 
the complement system [27]. Structurally, protein 
S has been subdivided into four different regions, 
the Gla region, the thrombin-sensitive region, the 
growth factor region, and the large carboxy- 
terminal region [22,23]. The homology between 
human SHBG and protein S is confined to the 
carboxy-terminal region of protein S, and SHBG is 
almost comparable in size to this region. It is 
noteworthy that the four half-cystine residues in 
SHBG seem to correspond to four of the five half- 
cystine residues present in the carboxy-terminal 
region of protein S. These four residues in protein 
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S form disulphide loops within the carboxy- 
terminal region. By analogy, we suggest that the 
corresponding half-cystines are disulphide bonded 
in SHBG, i.e. Cys164 to Cys~ss and Cys333 to 
cys361. 
The lowest degree of homology between SHBG 
and protein S is seen in the parts corresponding to 
residues 240 to 290 in SHBG (fig.2). This is 
noteworthy since this part of the SHBG molecule 
has been suggested to be responsible for the steroid 
binding property of SHBG [4]. It contains unusual 
structural features not recognizable in protein S, 
such as a long stretch of alternating leucine 
residues (residues 267-281) and a sequence repeat 
(residues 277-292 being a repeat of residues 
248-263). It is too early to speculate whether this 
reflects a more pronounced difference in function 
between these parts of the molecules since the 
steroid binding site of SHBG is not yet accurately 
mapped and the function of the carboxy-terminal 
region of protein S is largely unknown. 
Nonetheless, the finding of amino acid sequence 
homology between human SHBG and protein S 
from both the human and the cow throws new light 
on these proteins and may help in the elucidation 
of their function. 
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